OA
ACLX

Oracle Alpha’s Arcellx ACLX Stock Holding History

Oracle Alpha’s Portfolio ACLX Stock Details ACLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3,674
Closed -$204K – 188
2023
Q4 		$204K Buy
+3,674
New +$166K 0.26% 187

Other funds holding ACLX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Oracle Alpha's ACLX Position: Q1 2024 in Review

Oracle Alpha sold out of Arcellx (ACLX) in Q1 2024, closing a stake of 3,674 shares — an estimated $204K sold.

Oracle Alpha first reported a position in ACLX in Q4 2023 and held it in 1 quarter. The position peaked at $204K in Q4 2023. 183 funds tracked by Wall St. Rank hold ACLX as of Q1 2024.

  • Oracle Alpha reported no remaining Arcellx position as of Q1 2024 after selling out during the quarter.
  • Oracle Alpha sold 3,674 Arcellx shares in Q1 2024, an estimated $204K.
  • Oracle Alpha first reported a position in Arcellx in Q4 2023 and held it in 1 quarter.
  • Oracle Alpha's Arcellx position peaked at $204K in Q4 2023.
  • 183 funds tracked by Wall St. Rank held Arcellx as of Q1 2024.

Based on Oracle Alpha's 13F filing for Q1 2024, filed 15 May 2024.